Investors bought shares of UnitedHealth Group Inc. (NYSE:UNH) on weakness during trading on Thursday. $128.78 million flowed into the stock on the tick-up and $68.77 million flowed out of the stock on the tick-down, for a money net flow of $60.01 million into the stock. Of all stocks tracked, UnitedHealth Group had the 4th highest net in-flow for the day. UnitedHealth Group traded down ($0.64) for the day and closed at $140.84

A number of analysts have recently issued reports on UNH shares. Zacks Investment Research upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $146.00 target price for the company in a report on Wednesday, April 20th. Leerink Swann reiterated an “outperform” rating and set a $150.00 target price on shares of UnitedHealth Group in a report on Tuesday, April 19th. Cowen and Company reiterated an “outperform” rating on shares of UnitedHealth Group in a report on Tuesday, April 5th. Credit Suisse Group AG reiterated a “buy” rating on shares of UnitedHealth Group in a report on Wednesday, May 18th. Finally, Morgan Stanley reiterated a “buy” rating on shares of UnitedHealth Group in a report on Wednesday, May 18th. Two research analysts have rated the stock with a hold rating, twenty-one have given a buy rating and one has issued a strong buy rating to the company. The company presently has an average rating of “Buy” and a consensus target price of $146.02.

The stock has a 50-day moving average of $138.81 and a 200-day moving average of $126.93. The firm has a market capitalization of $134.38 billion and a P/E ratio of 22.72.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, April 19th. The healthcare conglomerate reported $1.81 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.72 by $0.09. During the same period in the prior year, the business earned $1.46 earnings per share. The company had revenue of $44.50 billion for the quarter, compared to the consensus estimate of $43.96 billion. The firm’s revenue for the quarter was up 24.5% on a year-over-year basis. Equities analysts expect that UnitedHealth Group Inc. will post $7.89 EPS for the current year.

The business also recently announced a quarterly dividend, which was paid on Tuesday, June 28th. Investors of record on Friday, June 17th were given a dividend of $0.625 per share. This represents a $2.50 annualized dividend and a yield of 1.77%. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $0.50. The ex-dividend date of this dividend was Wednesday, June 15th.

In related news, Director Gail R. Wilensky sold 5,500 shares of the firm’s stock in a transaction on Friday, June 10th. The stock was sold at an average price of $139.80, for a total transaction of $768,900.00. Following the completion of the transaction, the director now directly owns 59,019 shares of the company’s stock, valued at approximately $8,250,856.20. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director William C. Ballard, Jr. sold 5,000 shares of the firm’s stock in a transaction on Wednesday, April 20th. The stock was sold at an average price of $134.87, for a total value of $674,350.00. Following the transaction, the director now directly owns 73,229 shares of the company’s stock, valued at $9,876,395.23. The disclosure for this sale can be found here.

Several hedge funds and institutional investors have bought and sold shares of the company. Argent Trust Co raised its position in UnitedHealth Group by 0.5% in the third quarter. Argent Trust Co now owns 13,437 shares of the healthcare conglomerate’s stock valued at $1,559,000 after buying an additional 65 shares during the period. Mark Sheptoff Financial Planning LLC raised its position in UnitedHealth Group by 0.3% in the fourth quarter. Mark Sheptoff Financial Planning LLC now owns 36,079 shares of the healthcare conglomerate’s stock valued at $4,244,000 after buying an additional 103 shares during the period. Alerus Investment Advisors Corp raised its position in UnitedHealth Group by 0.4% in the fourth quarter. Alerus Investment Advisors Corp now owns 27,725 shares of the healthcare conglomerate’s stock valued at $3,262,000 after buying an additional 109 shares during the period. Mycio Wealth Partners LLC raised its position in UnitedHealth Group by 1.5% in the fourth quarter. Mycio Wealth Partners LLC now owns 10,487 shares of the healthcare conglomerate’s stock valued at $1,234,000 after buying an additional 150 shares during the period. Finally, Community Bank N.A. raised its position in UnitedHealth Group by 1.6% in the fourth quarter. Community Bank N.A. now owns 10,280 shares of the healthcare conglomerate’s stock valued at $1,209,000 after buying an additional 165 shares during the period.

UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.